APA (7th ed.) Citation

AL, P., P, P., P, C., SA, L., PS, L., KM, H., . . . KC, H. (2019). Treatment of type 1 diabetes with teplizumab: Clinical and immunological follow-up after 7 years from diagnosis. Diabetologia, 62(4), 655. https://doi.org/10.1007/s00125-018-4786-9

Chicago Style (17th ed.) Citation

AL, Perdigoto, et al. "Treatment of Type 1 Diabetes with Teplizumab: Clinical and Immunological Follow-up After 7 years from Diagnosis." Diabetologia 62, no. 4 (2019): 655. https://doi.org/10.1007/s00125-018-4786-9.

MLA (9th ed.) Citation

AL, Perdigoto, et al. "Treatment of Type 1 Diabetes with Teplizumab: Clinical and Immunological Follow-up After 7 years from Diagnosis." Diabetologia, vol. 62, no. 4, 2019, p. 655, https://doi.org/10.1007/s00125-018-4786-9.